Polymeric additives to enhance the functional properties of calcium phosphate cements

Journal of Tissue Engineering

Volumn 3, Issue 1, 2012, Pages 1-20

  Perez, Roman A ^a,b,c   Kim, Hae Won ^c,d,e   Ginebra, Maria Pau ^a,b  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

^d Dankook University   (South Korea)

^e Dankook University   (South Korea)

Author keywords

Calcium phosphate cement; Hydroxyapatite; Polymer

Indexed keywords

BONE; BONE CEMENT; CALCIUM PHOSPHATE; FLUORIDATION; HYDROXYAPATITE; TISSUE ENGINEERING; TOUGHNESS;

BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE CEMENT; CEMENT PASTE; ENTANGLED NETWORKS; FUNCTIONAL PROPERTIES; MINERAL PHASIS; MINIMALLY-INVASIVE SURGERY; NATURAL BONE; POLYMERIC ADDITIVES; REGENERATIVE MEDICINE;

BIOCOMPATIBILITY;

EID: 84863336901     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.1177/2041731412439555     Document Type: Article

References (147)

1. Arrington ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996; 329: 300-309.
2. Banwart JC, Asher MA and Hassanein RS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine 1995; 20(9): 1055-1060.
3. Ross N, Tacconi L and Miles JB. Heterotopic bone formation causing recurrent donor site pain following iliac crest bone harvesting. Br J Neurosurg 2000; 14(5): 476-479.
4. Seiler JG and Johnson J. Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc 2000; 9(2): 91-97.
5. Skaggs DL, Samuelson MA, Hale JM, et al. Complications of posterior iliac crest bone grafting in spine surgery in children. Spine 2000; 25(18): 2400-2402.
6. Summers BN and Eisenstein SM. Donor site pain from the ilium: a complication of lumbar spine fusion. J Bone Joint Surg Br 1989; 71(4):677-680.
7. Friedlaender GE, Strong DM, Tomford W, et al. Long-term follow-up of patients with osteochondral allografts. A correlation between immunologic responses and clinical outcome. Orthop Clin North Am 1999; 30(4): 583-588.
8. Dorozhkin SV. Calcium orthophosphates. J Mater Sci Mater Med 2007; 42(4): 1061-1095.
9. Ginebra MP, Fernandez E, De Maeyer EA, et al. Setting reaction and hardening of an apatitic calcium phosphate cement. J Dent Res 1997; 76(4): 905-912.
10. Driessens FC, Planell JA, Boltong MG, et al. Osteotransductive bone cements. Proc Inst Mech Eng H 1998; 212(6): 427-435.
11. Fernandez E, Boltong MG, Ginebra MP, et al. Development of a method to measure the period of swelling of calcium phosphate cements. J Mater Sci Lett 1996; 15(11): 1004-1005.
12. Ishikawa K, Miyamoto Y, Kon M, et al. Non-decay type fastsetting calcium phosphate cement: composite with sodium alginate. Biomaterials 1995; 16(7): 527-532.
13. Khairoun I, Boltong MG, Driessens FCM, et al. Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res 1997; 38(4): 356-360.
14. Khairoun I, Driessens FCM, Boltong MG, et al. Addition of cohesion promotors to calcium phosphate cements. Biomaterials 1999; 20(4): 393-398.
15. Andrianjatovo H and Lemaitre J. Effect of polysaccharides on the cement properties in the monocalcium phosphate monohydrate/β-tricalcium phosphate system. Innov Tech Biol Med 1995; 16(S1): 140-147.
16. Miyamoto Y, Ishikawa K, Takechi M, et al. Histological and compositional evaluations of three types of calcium phosphate cements when implanted in subcutaneous tissue immediately after mixing. J Biomed Mater Res A 1999; 48(1): 36-42.
17. Pioletti DP, Takei H, Lin T, et al. The effects of calcium phosphate cement particles on osteoblast functions. Biomaterials 2000; 21(11): 1103-1114.
18. Ishikawa K and Asaoka K. Estimation of ideal mechanical strength and critical porosity of calcium phosphate cement. J Biomed Mater Res A 1995; 29(12): 1537-1543.
19. Khairoun I, Boltong MG, Driessens FCM, et al. Some factors controlling the injectability of calcium phosphate bone cements. J Mater Sci Mater Med 1998; 9(8): 425-428.
20. Espanol M, Perez RA, Montufar EB, et al. Intrinsic porosity of calcium phosphate cements and its significance for drug delivery and tissue engineering applications. Acta Biomater 2009; 5(7): 2752-2762.
21. Ginebra MP, Delgado JA, Harr I, et al. Factors affecting the structure and properties of an injectable self-setting calcium phosphate foam. J Biomed Mater Res A 2007; 80(2): 351-361.
22. Del Valle S, Mino N, Munoz F, et al. In vivo evaluation of an injectable macroporous calcium phosphate cement. J Mater Sci Mater Med 2007; 18(2): 353-361.
23. Montufar EB, Traykova T, Schacht E, et al. Self-hardening calcium deficient hydroxyapatite/gelatin foams for bone regeneration. J Mater Sci Mater Med 2010; 21(3): 863-869.
24. Perut F, Montufar EB, Ciapetti G, et al. Novel soybean/ gelatine-based bioactive and injectable hydroxyapatite foam: material properties and cell response. Acta Biomater 2011; 7(4): 1780-1787.
25. Montufar EB, Traykova T, Planell JA, et al. Comparison of a low molecular weight and a macromolecular surfactant foaming agents for injectable self setting hydroxyapatite foams: polysorbate 80 versus gelatine. Mater Sci Eng C 2011; 31: 1498-1504.
26. Felix Lanao RP, Leeusenburgh SC, Wolke JG, et al. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. Acta Biomater 2011; 7(9): 3459-3468.
27. Zuo Y, Yang F, Wolke JG, et al. Incorporation of biodegradable electrospun fibers into calcium phosphate cement for bone regeneration. Acta Biomater 2010; 6(4): 1238-1247.
28. Perez RA, Ginebra MP and Spector M. Cell response to collagen- calcium phosphate cement scaffolds investigated for nonviral gene delivery. J Mater Sci Mater Med 2011; 22(4): 887-897.
29. Ginebra MP. Calcium phosphate bone cements. In: Deb S (ed.) Orthopaedic bone cements. Cambridge: Woodhead Publishing Limited, 2008, pp.206-230.
30. Canal C and Ginebra MP. Fibre-reinforced calcium phosphate cements: a review. J Mech Behav Biomed Mater 2011; 4(8): 1658-1671.
31. Engel E, Del Valle S, Aparicio C, et al. Discerning the role of topography and ion exchange in cell response of bioactive tissue engineering scaffolds. Tissue Eng Part A 2008; 14(8): 1341-1351.
32. Deligianni DD, Katsala ND, Koutsoukos PG, et al. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 2001; 22(1): 87-96.
33. Knabe C, Driessens FC, Planell JA, et al. Evaluation of calcium phosphates and experimental calcium phosphate bone cements using osteogenic cultures. J Biomed Mater Res 2000; 52(3): 498-508.
34. Link DP, Van den Dolder J, Wolke JG, et al. The cytocompatibility and early osteogenic characteristics of an injectable calcium phosphate cement. Tissue Eng 2007; 13(3): 493-500.
35. Yuasa T, Miyamoto Y, Ishikawa K, et al. Effects of apatite cements on proliferation and differentiation of human osteoblasts in vitro. Biomaterials 2004; 25(7-8): 1159-1166.
36. Oreffo RO, Driessens FCM, Planell JA, et al. Growth and differentiation of human bone marrow osteoprogenitors on novel calcium phosphate cements. Biomaterials 1998; 19(20): 1845-1854.
37. Perez RA, Del Valle S, Altankov G, et al. Porous hydroxyapatite and gelatin/hydroxyapatite microspheres obtained by calcium phosphate cement emulsion. J Biomed Mater Res B 2011; 97(1): 156-166.
38. Chiang TY, Ho CC, Chen DC, et al. Physicochemical properties and biocompatibility of chitosan oligosaccharide/gelatin/ calcium phosphate hybrid cements. Mater Chem Phys 2010; 120(2-3): 282-288.
39. Bigi A, Panzavolta S, Sturba L, et al. Normal and osteopenic bone-derived osteoblast response to a biomimetic gelatincalcium phosphate bone cement. J Biomed Mater Res A 2006; 78(4): 739-745.
40. Shie MY, Chen DC, Wang CY, et al. Immersion behavior of gelatin containing calcium phosphate cement. Acta Biomater 2008; 4(3): 646-655.
41. Yu T, Ye J, Gao C, et al. Effect of biomedical organic compounds on the setting reaction of calcium phosphates. Colloids Surf B Biointerfaces 2010; 75(1): 363-369.
42. Bigi A, Centelli I, Panzavolta S, et al. Alpha-tricalcium phosphate- gelatin composite cements. J Appl Biomater Biomech 2004; 2(4): 81-87.
43. Bigi A, Bracci B and Panzavolta S. Effect of added gelatin on the properties of calcium phosphate cement. Biomaterials 2004; 25(14): 2893-2899.
44. Fujishiro Y, Takahashi K and Sato T. Preparation and compressive strength of α-tricalcium phosphate/gelatin gel composite cement. J Biomed Mater Res 2001; 54(4): 525-530.
45. Moreau JL, Weir MD and Xu HH. Self-setting collagencalcium phosphate bone cement: mechanical and cellular properties. J Biomed Mater Res A 2009; 91(2): 605-613.
46. Tamimi F, Kumarasami B, Doillon C, et al. Brushite-collagen composites for bone regeneration. Acta Biomater 2008; 4(5): 1315-1321.
47. Miyamoto Y, Ishikawa K, Takechi M, et al. Basic properties of calcium phosphate cement containing atelocollagen in its liquid or powder phases. Biomaterials 1998; 19(7-9): 707-715.
48. Xu HH, Quinn JB, Takagi S, et al. Processing and properties of strong and non-rigid calcium phosphate cement. J Dent Res 2002; 81(3): 219-224.
49. Carey LE, Xu HH, Simon CG Jr, et al. Premixed rapid-setting calcium phosphate composites for bone repair. Biomaterials 2005; 26(24): 5002-5014.
50. Wang X, Ma J, Wang Y, et al. Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements. Biomaterials 2001; 22(16): 2247-2255.
51. Rau JV, Generosi A, Smirnov VV, et al. Energy dispersive X-ray diffraction study of phase development during hardening of calcium phosphate bone cements with addition of chitosan. Acta Biomater 2008; 4(4): 1089-1094.
52. Sun L, Xu HH, Tagaki S, et al. Fast setting calcium phosphate cement-chitosan composite: mechanical properties and dissolution rates. J Biomater Appl 2007; 21(3): 299-315.
53. Weir MD and Xu HH. Osteoblastic induction on calcium phosphate cement-chitosan constructs for bone tissue engineering. J Biomed Mater Res A 2010; 94(1): 223-233.
54. Zhou H, Weir MD and Xu HH. Effect of cell seeding density on proliferation and osteodifferentiation of umbilical cord stem cells on calcium phosphate cement-fiber scaffold. Tissue Eng Part A 2011; 17(21-22): 2603-2613.
55. Xu HH and Simon CG. Fast setting calcium phosphate-chitosan scaffold: mechanical properties and biocompatibility. Biomaterials 2005; 26(12): 1337-1348.
56. Zhao L, Burguera EF, Xu HH, et al. Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds. Biomaterials 2010; 31(5): 840-847.
57. Weir MD and Xu HH. Human bone marrow stem cell-encapsulating calcium phosphate scaffolds for bone repair. Acta Biomater 2010; 6(10): 4118-4126.
58. Weir MD and Xu HH. Culture human mesenchymal stem cells with calcium phosphate cement scaffolds for bone repair. J Biomed Mater Res B 2010; 93(1): 93-105.
59. Moreau JL and Xu HH. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate- chitosan composite scaffold. Biomaterials 2009; 30(14): 2675-2682.
60. Xu HH, Zhao L and Weir MD. Stem cell-calcium phosphate constructs for bone engineering. J Dent Res 2010; 89(12): 1482-1488.
61. Xu HH, Takagi S, Sun L, et al. Development of a nonrigid, durable calcium phosphate cement for use in periodontal bone repair. J Am Dent Assoc 2006; 137(8): 1131-1138.
62. Oh SA, Lee GS, Park JH, et al. Osteoclastic cell behaviors affected by the α-tricalcium phosphate based bone cements. J Mater Sci Mater Med 2010; 21(11): 3019-3027.
63. Maruyama M and Ito M. In vitro properties of a chitosanbonded self-hardening paste with hydroxyapatite granules. J Biomed Mater Res 1996; 32(4): 527-532.
64. Ito M, Miyazaki A, Yamagishi T, et al. Experimental development of a chitosan-bonded beta tricalcium phosphate bone filling paste. Biomed Mater Eng 1994; 4(6): 439-449.
65. Ito M, Yamagishi T, Yagasaki H, et al. In vitro properties of a chitosan-bonded bone filling paste studied on the solubility of calcium phosphate compounds. J Biomed Mater Res A 1996; 32(1): 95-98.
66. Takechi M, Miyamoto Y, Ishikawa K, et al. Initial histological evaluation of anti-washout type fast-setting calcium phosphate cement following subcutaneous implantation. Biomaterials 1998; 19(22): 2057-2063.
67. Zhang Y and Zhang M. Synthesis and characterization of macroporous chitosan/calcium phosphate composite scaffolds for tissue engineering. J Biomed Mater Res A 2001; 55(3): 304-312.
68. Wang X, Ma J, Wang Y, et al. Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements. Biomaterials 2002; 23(21): 4167-4176.
69. Weir MD and Xu HH. High-strength, in situ-setting calcium phosphate composite with protein release. J Biomed Mater Res A 2008; 85(2): 388-396.
70. Ishikawa K, Miyamoto Y, Takechi M, et al. Non-decay type fast-setting calcium phosphate cement: hydroxyapatite putty containing an increased amount of sodium alginate. J Biomed Mater Res 1997; 36(3): 393-399.
71. Chen CH, Chen CC, Shie MY, et al. Controlled release of gentamicin from calcium phosphate/alginate bone cement. Mater Sci Eng C 2011; 31(2): 334-341.
72. Dos Santos LA, De Oliveria LC, Rigo EC, et al. Influence of polymeric additives on the mechanical properties of alpha-tricalcium phosphate cement. Bone 1999; 25(2S): 99S-102S.
73. Tanaka S, Kishi T, Shimogoryo R, et al. Biopex acquires anti-washout properties by adding sodium alginate into its liquid phase. Dent Mater J 2003; 22(3): 301-312.
74. Park SH, Tofighi A, Wang X, et al. Calcium phosphate combination biomaterials as human mesenchymal stem cell delivery vehicles for bone repair. J Biomed Mater Res B 2011; 97(2): 235-244.
75. Alkhraisat MH, Rueda C, Marino FT, et al. The effect of hyaluronic acid on brushite cement cohesion. Acta Biomater 2009; 5(8): 3150-3156.
76. Sanginario V, Ginebra MP, Tanner KE, et al. Biodegradable and semi-biodegradable composite hydrogels as bone substitutes: morphology and mechanical characterization. J Mater Sci Mater Med 2006; 17(5): 447-454.
77. Kai D, Li D, Zhu X, et al. Addition of sodium hyaluronate and the effect on performance of the injectable calcium phosphate cement. J Mater Sci Mater Med 2009; 20(8): 1595-1602.
78. Takagi S, Chow LC, Hirayama S, et al. Premixed calcium- phosphate cement pastes. J Biomed Mater Res B 2003; 67(2): 689-696.
79. Cherng A, Takagi S and Chow LC. Effects of hydroxypropyl methylcellulose and other gelling agents on the handling properties of calcium phosphate cement. J Biomed Mater Res A 1997; 35(3): 273-277.
80. Burguera EF, Xu HH and Weir MD. Injectable and rapidsetting calcium phosphate bone cement with dicalcium phosphate dihydrate. J Biomed Mater Res B 2006; 77(1): 126-134.
81. Qu Y, Yang Y, Li J, et al. Preliminary evaluation of a novel strong/osteoinductive calcium phosphate cement. J Biomater Appl 2011; 26(3): 311-325.
82. Tamimi-Marino F, Mastio J, Rueda C, et al. Increase of the final setting time of brushite cements by using chondroitin 4-sulfate and silica gel. J Mater Sci Mater Med 2007; 18(6): 1195-1201.
83. Yokoyama A, Matsuno H, Yamamoto S, et al. Tissue response to a newly developed calcium phosphate cement containing succinic acid and carboxymethyl-chitin. J Biomed Mater Res A 2003; 64(3): 491-501.
84. Qi X, Ye J and Wang Y. Alginate/poly (lactic-co-glycolic acid)/calcium phosphate cement scaffold with oriented pore structure for bone tissue engineering. J Biomed Mater Res A 2009; 89(4): 980-987.
85. Lin J, Zhang S, Chen T, et al. Calcium phosphate cement reinforced by polypeptide copolymers. J Biomed Mater Res B 2006; 76(2): 432-439.
86. Chang CH, Liao TC, Hsu YM, et al. A poly(propylene fumarate)- calcium phosphate based angiogenic injectable bone cement for femoral head osteonecrosis. Biomaterials 2010; 31(14): 4048-4055.
87. Aberg J, Brisby H, Henriksson HB, et al. Premixed acidic calcium phosphate cement: characterization of strength and microstructure. J Biomed Mater Res B 2010; 93(2): 436-441.
88. Han B, Ma PW, Zhang LL, et al. Beta-TCP/MCPM-based premixed calcium phosphate cements. Acta Biomater 2009; 5(8): 3165-3177.
89. Wang X, Ye J and Wang H. Effects of additives on the rheological properties and injectability of a calcium phosphate bone substitute material. J Biomed Mater Res B 2006; 78(2): 259-264.
90. Leroux L, Hatim Z, Freche M, et al. Effects of various adjuvants (lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate cement. Bone 1999; 25(9): 31S-34S.
91. Bohner M, Lemaitre J, Van Landuyt P, et al. Gentamicinloaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci 1997; 86(5): 565-572.
92. Bohner M, Lemaitre J, Merckle HP, et al. Control of gentamicin release from a calcium phosphate admixed poly(acrylic acid). J Pharm Sci 2000; 89(10): 1262-1270.
93. Dos Santos LA, Carrodeguas RG, Boschi AO, et al. Dualsetting calcium phosphate cement modified with ammonium polyacrylate. Artif Organs 2003; 27(5): 412-418.
94. Khashaba RM, Moussa MM, Mettenburg DJ, et al. Polymeric-calcium phosphate cement composites-material properties: in vitro and in vivo investigations. Int J Biomater 2010; 2010. DOI: 10.1155/2010/691452
95. Cui G, Li J, Lei W, et al. The mechanical and biological properties of an injectable calcium phosphate cement-fibrin glue composite for bone regeneration. J Biomed Mater Res B 2010; 92(2): 377-385.
96. Habraken WJ, Wolke JG, Mikos AG, et al. Porcine gelatin microsphere/calcium phosphate cement composites: an in vitro degradation study. J Biomed Mater Res B 2009; 91(2): 555-561.
97. Harbraken WJ, De Jonge LT, Wolke JG, et al. Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A 2008; 87(3): 643-655.
98. Habraken WJ, Boerman OC, Wolke JG, et al. In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A 2009; 91(2): 614-622.
99. Cai S, Zhai Y, Xu G, et al. Preparation and properties of calcium phosphate cements incorporated gelatin microspheres and calcium sulfate dihydrate as controlled local drug delivery system. J Mater Sci Mater Med 2011; 22(11): 2487-2496.
100. Li M, Liu X, Liu X, et al. Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: a pilot study. Clin Orthop Relat Res 2010; 468(7): 1978-1985.
101. Li M, Liu X, Liu X, et al. Creation of macroporous calcium phosphate cement as bone substitutes by using genipincrosslinked gelatin microspheres. J Mater Sci Mater Med 2009; 20(4): 925-934.
102. Liao H, Walboomers XF, Habraken WJ, et al. Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect. Acta Biomater 2011; 7(4): 1752-1759.
103. Wang X, Chen L, Xiang H, et al. Influence of anti-washout agents on the rheological properties and injectability of a calcium phosphate. J Biomed Mater Res B 2007; 81(2): 410-418.
104. Alves HLR, dos Santos LA and Bergmann CP. Injectability evaluation of tricalcium phosphate bone cement. J Mater Sci Mater Med 2008; 19(5): 2241-2246.
105. Xu HH, Quinn JB, Takagi S, et al. Synergistic reinforcement of in situ hardening calcium phosphate composite scaffold for bone tissue engineering. Biomaterials 2004; 25(6): 1029-1037.
106. Simon CG, Guthrie WF and Wang FW. Cell seeding into calcium phosphate cement. J Biomed Mater Res A 2004; 68(4): 628-639.
107. Tang M, Weir MD and Xu HH. Mannitol-containing macroporous calcium phosphate cement encapsulating human umbilical cord stem cells. J Tissue Eng Regen Med. Epub ahead of print 27 March 2011. DOI: 10.1002/ term.419.
108. Zhao L, Tang M, Weir MD, et al. Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphatechitosan fibrous scaffold. Tissue Eng Part A 2011; 17(7-8): 969-979.
109. Habraken WJ, Liao HB, Zhang Z, et al. In vivo degradation of calcium phosphate cement incorporated into biodegradable microspheres. Acta Biomater 2010; 6(6): 2200-2211.
110. Ruhe PQ, Boerman OC, Russel FG, et al. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release 2005; 106(1-2): 162-171.
111. Ruhe PQ, Hedberg EL, Padron NT, et al. rhBMP-2 release from injectable poly(dl-lactic-co-glycolic acid)/calciumphosphate cement composites. J Bone Joint Surg Am 2003; 85(S3): 75-81.
112. Link DP, Van den Dolder J, Van den Beucken JJ, et al. Evaluation of the biocompatibility of calcium phosphate cement/PLGA microparticle composites. J Biomed Mater Res A 2008; 87(3): 760-769.
113. Van de Watering FC, Van den Beucken JJ, Walboomers XF, et al. Calcium phosphate/poly(d,l-lactic-co-glycolic acid) composite bone substitute materials: evaluation of temporal degradation and bone ingrowth in a rat critical-sized cranial defect. Clin Oral Implants Res. Epub ahead of print 2 June 2011. DOI: 10.1111/j.1600-0501.2011.02218.x.
114. Ruhe PQ, Hedberg-Dirk EL, Padron NT, et al. Porous poly(Dl-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 2006; 12(4): 789-800.
115. Schnieders J, Gbureck U, Thull R, et al. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-coglycolic acid) composite bone cement. Biomaterials 2006; 27(23): 4239-4249.
116. Fei Z, Hu Y, Wu D, et al. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement. J Mater Sci Mater Med 2008; 19(3): 1109-1116.
117. Zhang Y and Xu HH. Effects of synergistic reinforcement and absorbable fiber strength on hydroxyapatite bone cement. J Biomed Mater Res A 2005; 75(4): 832-840.
118. Zhao L, Weir MD and Xu HH. Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 2010; 31(14): 3848-3857.
119. Burguera EF, Xu HH, Takagi S, et al. High early strength calcium phosphate bone cement: effects of dicalcium phosphate dihydrate and absorbable fibers. J Biomed Mater Res A 2005; 75(4): 966-975.
120. Xu HH and Quinn JB. Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity. Biomaterials 2002; 23(1): 193-202.
121. Bao C, Chen W, Weir MD, et al. Effects of electrospun submicron fibers in calcium phosphate cement scaffold on mechanical properties and osteogenic differentiation of umbilical cord stem cells. Acta Biomater 2011; 7(11): 4037-4044.
122. Gorst NJ, Perrie Y, Gbureck U, et al. Effects of fibre reinforcement on the mechanical properties of brushite cement. Acta Biomater 2006; 2(1): 95-102.
123. Xu HH, Eichmiller FC and Giuseppetti AA. Reinforcement of a self-setting calcium phosphate cement with different fibers. J Biomed Mater Res A 2000; 52(1): 107-114.
124. Dos Santos LA, De Olveira LC, Da Silva Rigo EC, et al. Fiber reinforced calcium phosphate cement. Artif Organs 2000; 24(3): 212-216.
125. Majekodunmi AO, Deb S and Nicholson JW. Effect of molecular weight and concentration of poly(acrylic acid) on the formation of a polymeric calcium phosphate cement. J Mater Sci Mater Med 2003; 14(9): 747-752.
126. Hayashi A and Oh SC. Gelation of gelatin. Agric Biol Chem 1983; 47(6): 1711-1716.
127. Bigi A, Torricelli P, Fini M, et al. A biomimetic gelatincalcium phosphate bone cement. Int J Artif Organs 2004; 27(8): 664-673.
128. Miyazaki K, Horibe T, Antonucci JM, et al. Polymeric calcium phosphate cements: analysis of reaction products and properties. Dent Mater 1993; 9(1): 41-45.
129. Perez RA, Altankov G, Jorge-Herrero E, et al. Micro- and nanostructured hydroxyapatite-collagen microcarriers for bone tissue-engineering applications. J Tissue Eng Regen Med. Epub ahead of print 10 February 2012. DOI: 10.1002/ term.530.
130. Tagaki S, Chow LC, Hirayama S, et al. Properties of elastomeric calcium phosphate cement-chitosan composites. Dent Mater 2003; 19(8): 797-804.
131. Pan Z, Jiang P, Fan Q, et al. Mechanical and biocompatible influences of chitosan fiber and gelatin on calcium phosphate cement. J Biomed Mater Res B 2007; 82(1): 246-252.
132. Zhao L, Weir MD and Xu HH. An injectable calcium phosphate- alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 2010; 31(25): 6502-6510.
133. Rochet N, Balaguer T, Boukhechba F, et al. Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement. Biomaterials 2009; 30(26): 4260-4267.
134. Flautre B, Lemaitre J, Maynou C, et al. Influence of polymeric additives on the biological properties of brushite cements: an experimental study in rabbit. J Biomed Mater Res A 2003; 66(2): 214-223.
135. Ding T, Yang H, Maltenfort M, et al. Silk fibroin added to calcium phosphate cement to prevent severe cardiovascular complications. Med Sci Monit 2010; 16(9): HY23-HY26.
136. Wang X, Ma J, Feng Q, et al. Skeletal repair in rabbits with calcium phosphate cements incorporated phosphorylated chitin. Biomaterials 2002; 23(23): 4591-4600.
137. Xu HH, Carey LE, Simon CG Jr, et al. Premixed calcium phosphate cements: synthesis, physical properties, and cell cytotoxicity. Dent Mater 2007; 23(4): 433-441.
138. Chen WC, Ju CP, Wang JC, et al. Brittle and ductile adjustable cement derived from calcium phosphate cement/ polyacrylic acid composites. Dent Mater 2008; 24(12): 1616-1622.
139. Matsuya Y, Antonucci JM, Matsuya S, et al. Polymeric calcium phosphate cements derived from poly(methyl vinyl ether-maleic acid). Dent Mater 1996; 12(1): 2-7.
140. Boland EJ, MacDougall M, Carnes DL, et al. In vitro cytotoxicity of a remineralizing resin-based calcium phosphate cement. Dent Mater 2006; 22(4): 338-345.
141. Dickens SH, Schumacher GE, Flaim GM, et al. Pulp capping with a resin-based Ca-PO4 cement. J Dent Res, special issue 740, 2001; 80: Abstract 1710.
142. Kneser U, Voogd A, Ohnolz J, et al. Fibrin gel-immobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute. Cells Tissues Organs 2005; 179(4): 158-169.
143. Lian Q, Li DC, He JK, et al. Mechanical properties and invivo performance of calcium phosphate cement-chitosan fibre composite. Proc Inst Mech Eng H 2008; 222(3): 347-353.
144. Habraken WJ, Wolke JG, Mikos AG, et al. PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics. J Biomater Sci Polym Ed 2008; 19(9): 1171-1188.
145. Losquadro WD, Tatum SA, Allen MJ, et al. Archives of facial and plastic surgery. 2009; 11(2): 104-109.
146. Xu HH, Eichmiller FC and Guiseppetti AA. Strong and macroporous calcium phosphate cement: effects of porosity and fiber reinforcement on mechanical properties. J Biomed Mater Res A 2001; 57(1): 457-466.
147. Dunne N, Jack V, O'Hara R, et al. Performance of calcium deficient hydroxyapatite-polyglycolic acid composites: an in vitro study. J Mater Sci Mater Med 2010; 21(8): 2263-2270.